Showing 35,313 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

People who inject drugs

Half the picture – beyond drug overdose as a cause of death in opioid using people

Editor's pick
DrugScope
30 January 2015
Access to healthcare

Hepatitis C drug access: Europe is the new Africa

Editor's pick
HIV i-Base
30 January 2015
HIV testing programmes & uptake

HIV testing yields diagnoses in Kenya but few seek care

Editor's pick
Eurekalert Inf Dis
30 January 2015
Access to healthcare

Petition: Equitable access to HCV drugs

Editor's pick
Petitionbuzz
30 January 2015
Health problems & ageing

Herpes zoster incidence higher among patients with HIV

Editor's pick
Healio
30 January 2015
New & experimental HIV treatments

PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Editor's pick
Janssen press release
30 January 2015
New & experimental HIV treatments

U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Editor's pick
Bristol-Myers Squibb press release
30 January 2015
Bad science & bogus treatments

African American people’s AIDS conspiracy beliefs best understood in terms of social anxiety and distrust, not ignorance

News
29 January 2015
HIV prevention policy

Interview - Asia needs more cash, campaigns, law changes to end HIV epidemic - U.N

Editor's pick
Reuters
29 January 2015
Access to healthcare

Study Finds HIV Drugs Priced Out of Reach

Editor's pick
New York Times
29 January 2015
Access to healthcare

Russia may face shortage of anti-AIDS drugs in 2015

Editor's pick
EATG
29 January 2015
Transmission & prevention

European Advocates Engage with Biomedical Prevention

Editor's pick
AVAC
28 January 2015
Bad science & bogus treatments

Déjà Vu – Claims of HIV Cures and Re-Treading Old Ground

Editor's pick
Nigeria Health Watch
28 January 2015
Viral load

An HIV Doctor Tells You If Undetectable Really Is the New Negative

Editor's pick
The Body
28 January 2015
Neurological & cognitive problems

Antiretroviral Neurotoxicity May Cause Cognitive Problems

Editor's pick
The Body Pro
28 January 2015
Cardiovascular disease

Smoking is the main cause of increased risk of heart attack in people with HIV

News
28 January 2015
Behaviour change interventions

Condom advert – HIV prevention or infidelity promotion?

Editor's pick
Key Correspondents
27 January 2015
HIV & criminal law

Military justice?

Editor's pick
Positive Lite
27 January 2015
Dating, relationships & feelings

How to Talk to Your Partner About Using PrEP

Editor's pick
HIV Plus
27 January 2015
Access to healthcare

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

Editor's pick
Médecins Sans Frontières press release
27 January 2015
New & experimental hepatitis C treatment

Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

Editor's pick
Gilead press release
27 January 2015
Chemsex & recreational drug use

Managing crystal meth: tina and gay men

Editor's pick
Archer
26 January 2015
Harm reduction

Could a Syriza Win Spell Good News for Harm Reduction in Greece?

Editor's pick
Talking Drugs
26 January 2015
Adherence

Adherence packaging battles HIV/AIDS in Africa, India

Editor's pick
Packaging World
26 January 2015